These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3557620)

  • 1. Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae.
    Finn TM; Reiser J; Germanier R; Cryz SJ
    Infect Immun; 1987 Apr; 55(4):942-6. PubMed ID: 3557620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
    Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo adherence and colonization of Vibrio cholerae strains that differ in hemagglutinating activity and motility.
    Teppema JS; Guinée PA; Ibrahim AA; Pâques M; Ruitenberg EJ
    Infect Immun; 1987 Sep; 55(9):2093-102. PubMed ID: 3623694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.
    Cray WC; Tokunaga E; Pierce NF
    Infect Immun; 1983 Aug; 41(2):735-41. PubMed ID: 6874074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.
    Richardson K
    Infect Immun; 1991 Aug; 59(8):2727-36. PubMed ID: 1855990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The excretion pattern and protective capacity in rabbits orally immunized with attenuated strains of Vibrio cholerae O1 biotype El Tor].
    García Sánchez HM; García Imia L; Oliva Hernández R; Pérez Quiñoy JL; Cedré Marrero B; Domínguez Iriarte R; Benítez Robles J
    Rev Cubana Med Trop; 1998; 50(2):115-9. PubMed ID: 10349429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera.
    Silva AJ; Leitch GJ; Camilli A; Benitez JA
    Infect Immun; 2006 Apr; 74(4):2072-9. PubMed ID: 16552036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.
    Osek J; Svennerholm AM; Holmgren J
    Infect Immun; 1992 Nov; 60(11):4961-4. PubMed ID: 1356934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
    Tacket CO; Cohen MB; Wasserman SS; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper JB; Cryz SJ; Giannella RA; Schiff G; Levine MM
    Infect Immun; 1999 Dec; 67(12):6341-5. PubMed ID: 10569747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of immunogenicity and mechanisms of protection by virulent and mutant Vibrio cholerae O1 in rabbits.
    Pierce NF; Cray WC; Kaper JB; Mekalanos JJ
    Infect Immun; 1988 Jan; 56(1):142-8. PubMed ID: 2447017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic expression of a mannose-sensitive hemagglutinin by a Vibrio cholerae O1 E1Tor strain and evaluation of its role in intestinal adherence and colonization.
    Mukhopadhyay S; Ghosh C; Ghose AC
    FEMS Microbiol Lett; 1996 May; 138(2-3):227-32. PubMed ID: 9026451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
    Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Fasano A; Michalski J; Kaper JB; Levine MM
    J Infect Dis; 1993 Dec; 168(6):1536-40. PubMed ID: 8245542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of mannose-sensitive hemagglutinin (MSHA)-negative mutants of Vibrio cholerae derived by Tn5 mutagenesis.
    Häse CC; Bauer ME; Finkelstein RA
    Gene; 1994 Dec; 150(1):17-25. PubMed ID: 7959047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocellum endoglucanase A.
    Robert A; Silva A; Benitez JA; Rodriguez BL; Fando R; Campos J; Sengupta DK; Boesman-Finkelstein M; Finkelstein RA
    Vaccine; 1996 Nov; 14(16):1517-22. PubMed ID: 9014293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection.
    Lycke N; Svennerholm AM; Holmgren J
    Microb Pathog; 1986 Aug; 1(4):361-71. PubMed ID: 3508492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Vibrio cholerae recombinant strains on rabbit ileum in vivo. Enterotoxin production and myoelectric activity.
    Lind CD; Davis RH; Guerrant RL; Kaper JB; Mathias JR
    Gastroenterology; 1991 Aug; 101(2):319-24. PubMed ID: 2065905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.
    Honda T; Finkelstein RA
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2052-6. PubMed ID: 109838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.